Skip to main content
Log in

A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

Dopamine transporter single-photon emission computed tomography (DAT SPECT) has been widely used to diagnose Parkinson syndrome. Using the standardized uptake value (SUV) of DAT SPECT, we propose “functional dopamine transporter volume (f-DTV)” as a new quantitative index to evaluate the three-dimensional volume of functional dopamine transporters and assess its diagnostic ability in differentiating dopaminergic neurodegenerative diseases (dNDD) from non-dNDD.

Methods

Seventy-nine patients were enrolled (42 dNDD, 37 non-dNDD; 38 men; age 24–88 years). We analyzed seven quantitative indices. The specific binding ratio (SBR) was calculated using a program specialized for DAT SPECT (SBR_Bolt). The SUVmax, SUVpeak, and SUVmean were calculated using a quantification program for bone SPECT. SBR_SUV was calculated by dividing striatal SUVmean by the average of background SUVmean. The cutoff value of the active dopamine transporter level was examined using three methods (threshold of 40% of SUVmax, SUV 2, and SUV 3) to calculate the active dopamine transporter volume (ADV). The f-DTV was calculated by multiplying ADV and SUVmean. We assessed the correlations between SBR_Bolt and SBR_SUV, and compared the mean value of each index between the dNDD and non-dNDD groups. The abilities of SBR_Bolt, SBR_SUV, SUVmax, SUVpeak, SUVmean, ADV, and f-DTV in differentiating dNDD from non-dNDD were determined by the area under the receiver operating curve (AUC) generated by the receiver operating characteristics analysis.

Results

The SBR_Bolt and SBR_SUV highly correlated with each other (r = 0.71). The cutoff value of the active dopamine transporter level was determined as SUV 3. All seven quantitative indices showed lower values in the dNDD group than in the non-dNDD group, and the difference between the two groups was statistically significant (p < 0.05). Sensitivity, specificity, and AUC of f-DTV were slightly lower than those of SBR_Bolt (71%, 79%, and 0.81, respectively, for f-DTV, and 81%, 84%, 0.88, respectively, for SBR_Bolt). The difference in AUC between f-DTV and SBR_Bolt was not statistically significant.

Conclusions

This study demonstrates the utility of f-DTV as a novel quantitative index for evaluating the three-dimensional volume of functional dopamine transporters, and that f-DTV has almost the same diagnostic ability to differentiate dNDD from non-dNDD using DAT SPECT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Uyama N, Otsuka H, Shinya T, Otomi Y, Harada M, Sako W, et al. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes. Nucl Med Commun. 2017;38:487–92. https://doi.org/10.1097/MNM.0000000000000674.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kägi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry. 2010;81(1):5–12. https://doi.org/10.1136/jnnp.2008.157370.

    Article  PubMed  Google Scholar 

  3. Varrone A, Halldin C. Molecular imaging of the dopamine transporter. J Nucl Med. 2010;51(9):1331–4. https://doi.org/10.2967/jnumed.109.065656.

    Article  CAS  PubMed  Google Scholar 

  4. JSNM (Japanese Society of Nuclear Medicine). Clinical practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT ver.2 JSNM 2017

  5. Ueda J, Yoshimura H, Shimizu K, Hino M, Kohara N. Combined visual and semi-quantitative assessment of (123)I-FP-CIT SPECT for the diagnosis of dopaminergic neurodegenerative diseases. Neurol Sci. 2017;38:1187–91. https://doi.org/10.1007/s10072-017-2936-3.

    Article  PubMed  Google Scholar 

  6. Davidsson A, Georgiopoulos C, Dizdar N, Granerus G, Zachrisson H. Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson’s disease and atypical Parkinsonian syndromes using DaTSCAN® SPECT. Ann Nucl Med. 2014;28:851–9. https://doi.org/10.1007/s12149-014-0878-x.

    Article  CAS  PubMed  Google Scholar 

  7. Nicastro N, Garibotto V, Allali G, Assal F, Burkhard PR. Added value of combined semi-quantitative and visual [123I]FP-CIT SPECT analyses for the diagnosis of dementia with Lewy bodies. Clin Nucl Med. 2017;42:e96–102. https://doi.org/10.1097/RLU.0000000000001477.

    Article  PubMed  Google Scholar 

  8. Mäkinen E, Joutsa J, Johansson J, Mäki M, Seppänen M, Kaasinen V. Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism. J Neural Transm. 2016;123:1309–18. https://doi.org/10.1007/s00702-016-1586-6.1.

    Article  PubMed  Google Scholar 

  9. Tossici-Bolt L, Hoffmann S, Kemp P, Mehta R, Fleming J. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. EurJ Nucl Med Mol Iaging. 2006;33:1491–9. https://doi.org/10.1007/s00259-006-0155-x.

    Article  Google Scholar 

  10. Kaira K, Higuchi T, Naruse I. Metabolic activity by (18)F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC. Eur J Nucl Med Mol Imaging. 2018;45:56–66. https://doi.org/10.1007/s00259-017-3806-1.

    Article  CAS  PubMed  Google Scholar 

  11. Wei H, Weihao Z, Jiadong X, Hacker M, Bertling J, Lewis R, et al. Standardized uptake values of 99mTc-MDP SPECT bone scans - a novel method for absolute SPECT/CT quantification. J Nucl Med 2015;56(Suppl 3):1790

    Google Scholar 

  12. Kuji I, Yamane T, Seto A, Yasumizu Y, Shirotake S, Oyama M. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer. Eur J Hybrid Imaging. 2017;1:2. https://doi.org/10.1186/s41824-017-0006-y.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Toriihara A, Daisaki H, Yamaguchi A, Kobayashi M, Furukawa S, Yoshida K, et al. Semiquantitative analysis using standardized uptake value in 123I-FP-CIT SPECT/CT. Clin Imaging. 2018;52:57–61. https://doi.org/10.1016/j.clinimag.2018.06.009.

    Article  PubMed  Google Scholar 

  14. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:181–4. https://doi.org/10.1136/jnnp.55.3.181.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Catafau AM, Tolosa E. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord. 2004;19:1175–82. https://doi.org/10.1002/mds.20112.

    Article  PubMed  Google Scholar 

  16. Spiegel J, Hellwig D, Samnick S, Jost W, Möllers MO, Fassbender K, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson’s disease. J Neural Transm. 2007;114:331–5. https://doi.org/10.1007/s00702-006-0518-2.

    Article  CAS  PubMed  Google Scholar 

  17. Bieńkiewicz M, Górska-Chrzastek M, Siennicki J, Gajos A, Bogucki A, Mochecka-Thoelke A, et al. Impact of CT based attenuation correction on quantitative assessment of DaTSCAN ((123)I-Ioflupane) imaging in diagnosis of extrapyramidal diseases. Nucl Med Rev Cent East Eur. 2008;11:53–8.

    PubMed  Google Scholar 

  18. Miyai M, Yamamoto Y, Uchibe T, Yada N, Haramoto M, Katsube T, et al. Comparison of quantitative value of dopamine transporter scintigraphy calculated from different analytical software. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2015;71:1209–14. https://doi.org/10.6009/jjrt.2015_JSRT_71.12.1209 ([Article in Japanese]).

    Article  CAS  PubMed  Google Scholar 

  19. Tossici-Bolt L, Dickson JC, Sera T, Nijs R, Bagnara MC, Jonsson C, et al. Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database. Eur J Nucl Med Mol Imaging. 2011;38:1529–40. https://doi.org/10.1007/s00259-011-1801-5 (Epub 2011 Apr 6).

    Article  PubMed  Google Scholar 

  20. Tossici-Bolt L, Dickson JC, Sera T, Booij J, Asenbaun-Nan S, Bagnara MC, Borght TV, et al. [123I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods. EJNMMI Phys. 2017;4:8. https://doi.org/10.1186/s40658-017-0175-6 (Epub 2017 Jan 28).

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kameiyama H, Matsutomo N, Nagaki A, Fusae YF. Effect of reconstruction strategies for the quantification and diagnostic accuracy of (123)I-FP-CIT SPECT. Nihon Hoshasen Gijutsu Gakkai Zasshi. 2016;72:595–601. https://doi.org/10.6009/jjrt.2016_JSRT_72.7.595 (Article in Japanese).

    Article  PubMed  Google Scholar 

  22. Rahman MGM, Islam MM, Tsujikawa T, Kiyono Y, Okazawa H. Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis. Ann Nucl Med. 2019;33:14–21. https://doi.org/10.1007/s12149-018-1297-1 (Epub 2018 Oct 1).

    Article  CAS  PubMed  Google Scholar 

  23. Iwabuchi Y, Nakahara T, Kameyama M, Yamada Y, Hashimoto M, Ogata Y, et al. Quantitative evaluation of the tracer distribution in dopamine transporter SPECT for objective interpretation. Ann Nucl Med. 2018;32:363–71. https://doi.org/10.1007/s12149-018-1256-x (Epub 2018 Apr 13).

    Article  CAS  PubMed  Google Scholar 

  24. Iwabuchi Y, Nakahara T, Kameyama M, Yamada Y, Hashimoto M, Matsusaka Y, et al. Impact of a combination of quantitative indices representing uptake intensity, shape, and asymmetry in DAT SPECT using machine learning: comparison of different volume of interest settings. EJNMMI Res. 2019;9:7. https://doi.org/10.1186/s13550-019-0477-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Wakabayashi Y, Takahashi R, Kanda T, Zeng F, Nogami M, Ishii K, et al. Semi-quantitative dopamine transporter standardized uptake value in comparison with conventional specific binding ratio in 123I-FP-CIT single-photon emission computed tomography (DaTscan). Neurol Sci. 2018;39:1401–7. https://doi.org/10.1007/s10072-018-3437-8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideki Otsuka.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bando, R., Otsuka, H., Otani, T. et al. A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography. Ann Nucl Med 35, 504–513 (2021). https://doi.org/10.1007/s12149-021-01592-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-021-01592-w

Keywords

Navigation